Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

Radiotherapy 10Magnetic Resonance Spectroscopy 7Early Intervention, Educational 7Standard of Care 6Interviews as Topic 6Educational Status 6Radiotherapy, Conformal 5Practice Guidelines as Topic 5Methods 5Cyclophosphamide 5Vincristine 4Specimen Handling 4Psychiatric Rehabilitation 4Cisplatin 4Brachytherapy 4Biopsy 4Surgical Procedures, Operative 3Radiosurgery 3Granulocyte Colony-Stimulating Factor 3Fluorodeoxyglucose F18 3Filgrastim 3Etoposide 3Dexamethasone 3Counseling 3Carboplatin 3pegaspargase 2motexafin gadolinium 2etoposide phosphate 2X-Rays 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × NETWORK × Genetic Profile × Clear all
NCT05455606 2026-01-22

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

SWOG Cancer Research Network

Phase NA Active not recruiting
1,284 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡